Akerna Flash Report: 4/20 Cannabis Sales Reached $154.4M, Setting New Single-Day Sales Record

Akerna KERN announced that this year's 4/20 holiday broke all previous cannabis retail records, bringing in a total of $154.4 million in adult-use and medicinal sales.

The company noted that compared to last year's 4/20, which until last week was the industry's largest sales day to date and brought in nearly $112 million, this year's 4/20 was a significant 38.1% growth over last year's.

When looking at the period around 4/20, according to Akerna, US shoppers spent a total of $485.3 million on cannabis products.

To put that into perspective, the Iowa Alcoholic Beverages Division recently reported the state's largest year of liquor sales ever – which surpassed $400 million for the first time. This means that the U.S. cannabis retail industry brought in more sales in just six days than Iowa did for liquor sales in a record-breaking year of their own.

"Using our historical Akerna data, we released a prediction report that the period around 4/20 would bring in a total of $494 million, only –1.79% variance from the actual sales of $485.3 million. This is a testament to the power of our data analytics. By leveraging data-driven insights, cannabis businesses can make strategic predictions and decisions for their businesses," stated James Ahrendt, business intelligence architect at Akerna.

Akerna data shows increases in cannabis sales market share for women shoppers over the past few years. This trend continued with this 4/20, with women's market share of sales breaking the 40% mark for the first time ever.

As more markets legalize cannabis and more Americans become comfortable with the legal cannabis industry, these year-over-year increases are expected to continue. Data shows cannabis has a broad appeal to people of all demographics.

Other predicted values for the long holiday weekend (4/15 - 4/20)

  • Category sales:

  • Flower – 48.11%

  • Cartridge/Pens – 31.66%

  • Concentrates – 11.63%

  • Infused Edibles – 6.87%

  • Infused Non-Edible – 0.71%

  • Non-Medicated – 1.01%

Sales by demographic:

  • Men - 59.93%

  • Women - 40.07%

Sales by age groups:

  • Under 30 – 28.38%

  • 30-40 –30.43%

  • 40-50 – 19.92%

  • 50-60 – 11.49%

  • Over 60 – 9.78%

  • Photo: Courtesy of Shelby Ireland on Unsplash

Related News

Akerna Flash Predicts 420 To Bring In Over $130M In Legal Cannabis Sales; Will It Be The Largest Sales Day Ever?

Decentralized Opportunities: How Cannabis Could Factor Into Web3, The Metaverse

Akerna Reports 61% YoY Increase In Q4 Revenue, Wider Net Loss

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsPenny StocksMarketsJames Ahrendt
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.